Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind placebo-controlled RCT of intramuscular botulinum toxin A for provoked vestibulodynia
2016-000375-25Phase 3Completed
- Sponsor
- Danderyds sjukhus
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in vestibulodynia comparing Botulinum toxin A with Placebo (2 arms). Primary endpoint: Change in dyspareunia and tampon insertion pain (VAS 0–100 mm). Started Feb 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
vestibulodynia
Beyond the preview
Go deeper on 2016-000375-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000375-25.